Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Upgrades Price Target for Hess Midstream to 38

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
MMM stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

UBS analyst Brian Reynolds is bullish on Hess Midstream (NYSE:HESM), maintaining a Buy rating and increasing the price target to $38, up from $35. This adjustment signifies a strong belief in the company’s future performance. Previously, UBS had a Buy rating but had lowered the price target to $36. The current forecast suggests an average 12-month price target of $36.33 for Hess Midstream Partners, indicating a potential upside of 4.83% according to analysts’ projections.

HESM Stock Shows Strong Performance on March 2, 2024: Potential for Continued Growth

On March 2, 2024, HESM stock had a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time and may have strong potential for continued growth.

The price of HESM shares increased by $0.55 since the market last closed, representing a 1.61% rise. This is a positive sign for investors, as it shows that the stock is gaining value. However, it is important to note that the stock closed at $34.64, which means that it is still relatively affordable for investors looking to buy in.

Overall, HESM stock had a strong performance on March 2, 2024, with a price increase during regular trading hours. Investors should continue to monitor the stock’s performance and consider factors such as market trends, company news, and financial reports when making investment decisions.

HESM Stock Performance Analysis: Promising Results and Growth Potential for Investors

On March 2, 2024, HESM stock performance showed promising results based on the financial data provided by CNN Money. The company reported a total revenue of $1.35 billion for the past year, with a slight increase of 5.76% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $356.50 million.

Net income for HESM was reported at $118.60 million for the past year, showing a significant increase of 41.36% compared to the previous year. Similar to the total revenue, the net income also remained flat since the last quarter, with a reported figure of $37.50 million.

Earnings per share (EPS) for HESM stood at $2.11 for the past year, reflecting a modest increase of 3.95% compared to the previous year. The EPS remained unchanged since the last quarter, at $0.55.

Overall, HESM’s financial performance indicates a positive trend with increasing net income and earnings per share. The company’s ability to maintain steady revenue growth despite fluctuations in the market is a good sign for investors. However, the flat performance since the last quarter may raise some concerns about the company’s future growth prospects.

Investors and analysts will be closely monitoring HESM’s performance in the coming quarters to see if the company can sustain its growth momentum and continue to deliver strong financial results. With a solid track record of increasing net income and earnings per share, HESM remains a stock to watch in the market.

Tags: HESM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
OHI stock news

UBS Analyst Maintains Neutral Rating on Main Street Capital with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Reaffirms Neutral Rating on PayPal Holdings with Increased Price Target

Finance_Commercial (2)

Analysts Provide Mixed Ratings for NetApp Following Strong Q3 Earnings

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com